150 related articles for article (PubMed ID: 36503310)
1. MiToS and King's staging as clinical outcome measures in ALS: a retrospective analysis of the FORTITUDE-ALS trial.
Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Chiò A; Andrews JA; Genge A; Jackson CE; Lechtzin N; Miller TM; Shefner JM
Amyotroph Lateral Scler Frontotemporal Degener; 2023 May; 24(3-4):304-310. PubMed ID: 36503310
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ability of the King's and MiToS staging systems to predict disease progression and survival in amyotrophic lateral sclerosis.
Luna J; Couratier P; Lahmadi S; Lautrette G; Fontana A; Tortelli R; Logroscino G; Preux PM; Copetti M; Benoit M
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):478-485. PubMed ID: 33829938
[No Abstract] [Full Text] [Related]
3. Comparison of the King's and MiToS staging systems for ALS.
Fang T; Al Khleifat A; Stahl DR; Lazo La Torre C; Murphy C; ; Young C; Shaw PJ; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):227-232. PubMed ID: 28054828
[TBL] [Abstract][Full Text] [Related]
4. Clinical staging in amyotrophic lateral sclerosis: analysis of Edaravone Study 19.
Al-Chalabi A; Chiò A; Merrill C; Oster G; Bornheimer R; Agnese W; Apple S
J Neurol Neurosurg Psychiatry; 2021 Feb; 92(2):165-171. PubMed ID: 33109706
[TBL] [Abstract][Full Text] [Related]
5. The utility of ALS staging systems in a multi-ethnic patient cohort.
Abdul Aziz NA; Toh TH; Loh EC; Capelle DP; Goh KJ; Abdul Latif L; Chung TY; Shahrizaila N
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):341-349. PubMed ID: 33726578
[No Abstract] [Full Text] [Related]
6. Health utilities and quality-adjusted life years for patients with amyotrophic lateral sclerosis receiving
Gebrehiwet P; Meng L; Rudnicki SA; Sarocco P; Wei J; Wolff AA; Butzner M; Chiò A; Andrews JA; Genge A; Hughes DA; Jackson CE; Lechtzin N; Miller TM; Shefner JM
J Med Econ; 2023; 26(1):488-493. PubMed ID: 36930042
[TBL] [Abstract][Full Text] [Related]
7. Deconstructing progression of amyotrophic lateral sclerosis in stages: a Markov modeling approach.
Thakore NJ; Lapin BR; Kinzy TG; Pioro EP
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):483-494. PubMed ID: 30001159
[TBL] [Abstract][Full Text] [Related]
8. Amyotrophic lateral sclerosis: a comparison of two staging systems in a population-based study.
Ferraro D; Consonni D; Fini N; Fasano A; Del Giovane C; ; Mandrioli J
Eur J Neurol; 2016 Sep; 23(9):1426-32. PubMed ID: 27238551
[TBL] [Abstract][Full Text] [Related]
9. Stage at which riluzole treatment prolongs survival in patients with amyotrophic lateral sclerosis: a retrospective analysis of data from a dose-ranging study.
Fang T; Al Khleifat A; Meurgey JH; Jones A; Leigh PN; Bensimon G; Al-Chalabi A
Lancet Neurol; 2018 May; 17(5):416-422. PubMed ID: 29525492
[TBL] [Abstract][Full Text] [Related]
10. Prescription and acceptance of durable medical equipment in FORTITUDE-ALS, a study of
Rudnicki SA; Andrews JA; Genge A; Jackson C; Lechtzin N; Miller TM; Cockroft BM; Malik FI; Meng L; Wei J; Wolff AA; Shefner JM;
Amyotroph Lateral Scler Frontotemporal Degener; 2022 May; 23(3-4):263-270. PubMed ID: 34218726
[No Abstract] [Full Text] [Related]
11. The MITOS system predicts long-term survival in amyotrophic lateral sclerosis.
Tramacere I; Dalla Bella E; Chiò A; Mora G; Filippini G; Lauria G;
J Neurol Neurosurg Psychiatry; 2015 Nov; 86(11):1180-5. PubMed ID: 25886781
[TBL] [Abstract][Full Text] [Related]
12. Milano-Torino Staging and Long-Term Survival in Chinese Patients with Amyotrophic Lateral Sclerosis.
He R; Zheng M; Lian L; Yao X
Cells; 2021 May; 10(5):. PubMed ID: 34067647
[TBL] [Abstract][Full Text] [Related]
13. Intuitive Staging Correlates With King's Clinical Stage.
Al Khleifat A; Balendra R; Fang T; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug; 22(5-6):336-340. PubMed ID: 33821690
[No Abstract] [Full Text] [Related]
14. Staging model for amyotrophic lateral sclerosis in Singapore.
Tay YT; H Chai JY; Shekh Jabin KB; Ang K
Singapore Med J; 2022 Jul; 63(7):371-375. PubMed ID: 33472335
[TBL] [Abstract][Full Text] [Related]
15. COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success.
Shefner JM; Al-Chalabi A; Andrews JA; Chio A; De Carvalho M; Cockroft BM; Corcia P; Couratier P; Cudkowicz ME; Genge A; Hardiman O; Heiman-Patterson T; Henderson RD; Ingre C; Jackson CE; Johnston W; Lechtzin N; Ludolph A; Maragakis NJ; Miller TM; Mora Pardina JS; Petri S; Simmons Z; Van Den Berg LH; Zinman L; Kupfer S; Malik FI; Meng L; Simkins TJ; Wei J; Wolff AA; Rudnicki SA
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):523-534. PubMed ID: 37254449
[No Abstract] [Full Text] [Related]
16. Healthcare resource utilization at different stages of amyotrophic lateral sclerosis: Results from a real-world survey.
Stenson K; O'Callaghan L; Mellor J; Wright J; Gibson G; Earl L; Barlow S; Fournier CN
J Neurol Sci; 2023 Sep; 452():120764. PubMed ID: 37639764
[TBL] [Abstract][Full Text] [Related]
17. Comparison Of King's Clinical Staging In Multinational Amyotrophic Lateral Sclerosis Cohorts.
Balendra R; Jones AR; Al Khleifat A; Chiwera T; Wicks P; Young CA; Shaw PJ; Turner MR; Leigh PN; Al-Chalabi A
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Feb; 24(1-2):71-81. PubMed ID: 35852375
[No Abstract] [Full Text] [Related]
18. Staging amyotrophic lateral sclerosis: A new focus on progression.
Corcia P; Beltran S; Lautrette G; Bakkouche S; Couratier P
Rev Neurol (Paris); 2019 May; 175(5):277-282. PubMed ID: 30606512
[TBL] [Abstract][Full Text] [Related]
19. Neurophysiological indices in amyotrophic lateral sclerosis correlate with functional outcome measures, staging and disease progression.
Barp A; Lizio A; Gerardi F; Tarlarini C; Mauro L; Sansone VA; Lunetta C
Clin Neurophysiol; 2021 Jul; 132(7):1564-1571. PubMed ID: 34023632
[TBL] [Abstract][Full Text] [Related]
20. Disease survival and progression in TARDBP ALS patients from Sardinia, Italy.
Borghero G; Pili F; Muroni A; Ercoli T; Pateri MI; Pilotto S; Maccabeo A; Defazio G
J Neurol; 2024 Feb; 271(2):929-934. PubMed ID: 37855870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
